Guselkumab Clinical Trials

13 recruitingDrug
Phase 35Phase 44Phase 23Not Applicable1

Showing 113 of 13 trials

Recruiting
Phase 3

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease
Janssen Research & Development, LLC120 enrolled83 locationsNCT05923073
Recruiting
Phase 4

Multi-Center PAMPA Study

Psoriasis
NYU Langone Health176 enrolled5 locationsNCT05004727
Recruiting
Phase 4

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Arthritis, Psoriatic
Johnson & Johnson Private Limited100 enrolled8 locationsNCT07141004
Recruiting
Phase 3

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

Crohn's Disease
Janssen-Cilag Ltd.112 enrolled84 locationsNCT06408935
Recruiting
Phase 3

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Crohns Disease
Janssen Research & Development, LLC196 enrolled30 locationsNCT06663332
Recruiting
Phase 2

Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Pyoderma GangrenosumWound HealSkin Diseases+2 more
Oregon Health and Science University17 enrolled2 locationsNCT06563323
Recruiting
Phase 2

Efficacy of Guselkumab in Treating Hailey Hailey Disease

Hailey Hailey Disease
Yale University10 enrolled1 locationNCT06651489
Recruiting
Phase 2Phase 3

Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation

Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 3

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

Psoriatic Arthritis
University of Pennsylvania63 enrolled14 locationsNCT05669833
Recruiting
Phase 4

Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

Psoriasis Arthritis
Fondazione Policlinico Universitario Campus Bio-Medico26 enrolled1 locationNCT06974474
Recruiting
Not Applicable

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

Psoriatic Arthritis
University of California, San Diego20 enrolled1 locationNCT06586281
Recruiting

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

PregnancyCrohn DiseasePsoriasis+1 more
University of California, San Diego200 enrolled1 locationNCT02103361
Recruiting
Phase 4

Immune Spatial Features of Guselkumab Cutaneous Response

Psoriasis of Scalp
University of California, San Francisco10 enrolled1 locationNCT05858632